Filing Details

Accession Number:
0001171843-21-002446
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-13 11:33:42
Reporting Period:
2021-04-12
Accepted Time:
2021-04-13 11:33:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1684144 Zomedica Corp. ZOM Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1721793 Stephanie Morley C/o Zomedica Corp.
100 Phoenix Drive, Suite 125
Ann Arbor MI 48108
President & Cmo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Without Par Value Acquisiton 2021-04-12 305,000 $0.19 1,764,580 No 4 M Direct
Common Stock, Without Par Value Disposition 2021-04-12 305,000 $1.16 1,459,580 No 4 S Direct
Common Stock, Without Par Value Acquisiton 2021-04-12 500,000 $0.43 1,959,580 No 4 M Direct
Common Stock, Without Par Value Disposition 2021-04-12 500,000 $1.16 1,459,580 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Without Par Value Stock option (right to buy) Disposition 2021-04-12 305,000 $0.00 305,000 $0.19
Common Stock, Without Par Value Stock option (right to buy) Disposition 2021-04-12 500,000 $0.00 500,000 $0.43
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
445,000 2025-03-14 No 4 M Direct
0 2019-09-16 2021-09-16 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, Without Par Value 1,000 Indirect By daughter
Common Stock, Without Par Value 1,000 Indirect By daughter
Common Stock, Without Par Value 1,000 Indirect By step-daughter
Common Stock, Without Par Value 1,000 Indirect By step-son
Common Stock, Without Par Value 1,000 Indirect By step-son
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 22, 2021.
  2. The option vests in 4 equal annual installments commencing March 13, 2020.